In vivo quantification of human pulmonary β-adrenoceptors: Effect of β-agonist therapy

American Journal of Respiratory and Critical Care Medicine

Volumn 154, Issue 5, 1996, Pages 1277-1283

  Hayes, Michael J ^b   Qing, Feng ^b   Rhodes, Christopher G ^b   Rahman, Shakil U ^b   Ind, Philip W ^b   Sriskandan, Shiranee ^b   Jones, Terry ^b   Hughes, J M B ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE; SALBUTAMOL;

ADULT; AIRWAY CONDUCTANCE; ARTICLE; BRONCHODILATATION; CATECHOLAMINE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG RECEPTOR BINDING; HUMAN; HUMAN EXPERIMENT; LIGAND BINDING; MALE; MONOCYTE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION;

EID: 0029804448     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.154.5.8912736     Document Type: Article

References (35)

1. Jackson, R., M. R. Sears, R. Beaglehole, and H. H. Rea. 1988. International trends in asthma mortality: 1970 to 1985. Chest 94:914-918.
2. Grainger, J., K. Woodman, N. Pearce, J. Crane, C. Burgess, A. Keane, and R. Beasley. 1991. Prescribed fenoterol and death from asthma in New Zealand, 1981-1987: a further case-control study. Thorax 46:105-111.
3. Spitzer, W. O., S. Suissa, P. Ernst, R. I. Horwitz, B. Habbick, D. Cockcroft, J. F. Boivin, M. McNutt, A. S. Buist, and A. S. Rebuck. 1992. The use of beta-agonists and the risk of death and near death from asthma. N. Engl. J. Med. 326:501-506.
4. Sears, M. R., D. R. Taylor, C. G. Prim, D. C. Lake, Q. Q. Li, E. M. Flannery, D. M. Yates, M. K. Lucas, and G. P. Herbison. 1990. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 336: 1391-1396.
5. Chapman, K., S. Kesten, and J. Szalai. 1994. Regular versus as-needed albuterol in asthma control. Lancet 343:1379-1382.
6. Lipworth, B. J., A. D. Struthers, and D. G. McDevitt. 1989. Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled albuterol in asthmatics. Am. Rev. Respir. Dis. 140:586-592.
7. Holgate, S. T., C. J. Baldwin, and A. E. Tattersfield. 1977. Beta-adrenergic agonist resistance in normal human airways. Lancet 2:375-377.
8. Gibson, G. J., J. K. Greenacre, P. Konig, M. E. Conolly, and N. B. Pride. 1978. Use of exercise challenge to investigate possible tolerance to bela-adrenoceptor stimulation in asthma. Br. J. Dis. Chest 72:199-206.
9. Cockcroft, D. W., C. P. McParland, S. A. Britto, V. A. Swystun, and B. C. Rutherford. 1993. Regular inhaled albuterol and airway responsiveness to allergen. Lancet 342:833-837.
10. Insel, P., L. Mahan, H. Motulsky, L. Stoolman, and A. Koachman. 1983. Time dependent decreases in binding affinity of agonists for beta adrenergic receptors of intact S49 lymphoma cells. J. Biol. Chem. 258:13597-13605.
11. Su, Y.-F., K. Harden, and J. Perkins. 1980. Catecholamine specific desensitization of adenylate cyclase. J. Biol. Chem. 255:7410-7419.
12. De Blasi, A., M. Lipartiti, H. J. Motulsky, P. A. Insel, and M. Fratelli. 1985. Agonist-induced redistribution of beta-adrenergic receptors on intact human mononuclear leukocytes: redistributed receptors are non-functional. J. Clin. Endocrinol. Metab. 61:1081-1088.
13. Nishikawa, M., J. Mak, H. Shirasaki, S. Harding, and P. Barnes. 1994. Long-term exposure to norepinephrine results in down-regulation and reduced mRNA expression of pulmonary beta-adrenergic receptors in guinea pigs. Am. J. Respir. Cell Mol. Biol. 10:91-99.
14. Brodde, O. E., A. Daul, M. R. Michel, F. Boomsma, A. J. Man in't Veld, P. Schlieper, and M. C. Michel. 1990. Agonist-induced desensitization of beta-adrenoceptor function in humans: subtype-selective reduction in beta 1- or beta 2-adrenoceptor-mediated physiological effects by xamoterol or procaterol. Circulation 81:914-921.
15. Martinsson, A., K. Larsson, and P. Hjemdahl. 1987. Studies in vivo and in vitro of terbutaline-induced beta-adrenoceptor desensitization in healthy subjects. Clin. Sci. 72:47-54.
16. Van de Berg, W., J. G. Leferink, J. K. Fokkens, J. Kreukniet, R. A. Macs, and P. L. Bruynzeel. 1982. Clinical implications of drug-induced desensitization of the beta receptor after continuous oral use of terbutaline. J. Allergy Clin. Immunol. 69:410-417.
17. Carstairs, J. R., A. J. Nimmo, P. J. Barnes. 1985. Autoradiographic visualization of beta-adrenoceptor subtypes in human lung. Am. Rev. Respir. Dis. 132:541-547.
18. Hauck, R. W., M. Bohm, S. Gengenbach, P. L. Sunder, G. Fruhmann, and E. Erdmann. 1990. Beta 2-adrenoceptors in human lung and peripheral mononuclear leukocytes of untreated and terbutaline-treated patients. Chest 98:376-381.
19. Delforge, J., A. Syrota, J.-P. Lancon, K. Nakajima, C. Loc'h, M. Janier, J. Vallois, J. Cayla, and C. Crouzel. 1991. Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP12177, and a new graphical method. J. Nucl. Med. 32:739-748.
20. 11C]-CGP-12177 and PET. J. Appl. Physiol. 75:559-565.
21. Qing, F., C. G. Rhodes, M. J. Hayes, T. Krausz, S. W. Fountain, T. Jones, and J. M. B. Hughes. In vivo quantification of human pulmonary β-adrenoceptor density using PET: comparison with in vitro radioligand binding. J. Nucl. Med. (In press)
22. Rhodes, C. G., P. Wollmer, F. Fazio, and T. Jones. 1981. Quantitative measurement of regional extravascular lung density using positron emission and transmission tomography. J. Comput. Assist. Tomogr. 5:783-791.
23. Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Lab. Clin. Invest. 21(Suppl. 97):77-89.
24. McCarthy, P. T., S. Atwal, A. P. Sykes, and J. G. Ayres. 1993. Measurement of terbutaline and albuterol in plasma by high performance liquid chromatography with fluorescence detection. Biomed. Chromatogr. 7:25-28.
25. Lefroy, D. C., R. de Silva, L. Choudhury, N. G. Uren, T. Crake, C. G. Rhodes, A. A. Lammertsma, H. Boyd, P. N. Patsalos, P. Nihoyannopoulos, C. M. Oakley, T. Jones, and P. G. Camici. 1993. Diffuse reduction of myocardial beta-adrenoceptors in hypertrophic cardiomyopathy: a study with positron emission tomography. J. Am. Coll. Cardiol. 22:1653-1660.
26. Liggett, S. B., J. C. Marker, S. D. Shah, C. L. Roper, and P. E. Cryer. 1988. Direct relationship between mononuclear leukocyte and lung β-adrenergic receptors and apparent reciprocal regulation of extravascular, but not intravascular, α- and β-adrenergic receptors by the sympathochromaffin system in humans. J. Clin. Invest. 82:48-56.
27. Connolly, M., J. Crowley, C. Nielson, N. Charan, and R. Vestal. 1994. Peripheral mononuclear leucocyte beta adrenoceptors and non-specific bronchial response to methacholine in young and elderly normal subjects and asthmatic patients. Thorax 49:26-32.
28. Barnes, P. J. 1995. Beta-adrenergic receptors and their regulation. Am. J. Respir. Crit. Care Med. 152:838-860.
29. 2-adrenergic receptor in normal and asthmatic subjects. Am. J. Respir. Cell Mol. Biol. 8:334-339.
30. Turki, J., S. A. Green, K. B. Newman, M. A. Meyers, and S. B. Liggett. 1995. Human lung cell β2-adrenergic receptors desensitize in response to in vivo administered β-agonist. Am. J. Physiol. 269 (Lung Cell Mol. Physiol. 13):L709-L714.
31. Harvey, J. E., and A. E. Tattersfield. 1982. Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects. Thorax 37:280-287.
32. 2-adrenoceptor messenger RNA in human and rat lung using in situ hybridization: correlation with receptor autoradiography. Eur. J. Pharmacol. (Molec. Pharmacol.) 206:133-138.
33. Law, M. 1993. Demonstration of the suitability of CGP 12177 for in vivo studies of β-adrenoceptors. Br. J. Pharmacol. 109:1101-1109.
34. van Koppen, C., M. Hermanussen, K. Verrijp, J. F. Rodrigues de Miranda, A. Beld, J. Lammers, and C. van Ginneken. 1987. β-adrenoceptors in human tracheal smooth muscle: characteristics of binding and relaxation. Life Sci. 40:2561-2570.
35. Toews, M. L., T. K. Harden, and J. P. Perkins. 1983. High-affinity binding of agonists to β-adrenergic receptors on intact cells. Proc. Natl. Acad. Sci. U.S.A. 80:3553-3557.